Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07070882 · ClinicalTrials.gov registry record · Phase 1
Oral Steroid Taper After Total Knee Arthroplasty
A Phase 1 study of Osteoarthritis, Knee, sponsored by Columbia University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT07070882 is a Phase 1 study of Osteoarthritis, Knee that is actively recruiting participants, run by Columbia University. The registered enrollment target is 130 participants, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07070882, a Phase 1 study of Osteoarthritis, Knee, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the effectiveness of an oral methylprednisolone taper in reducing postoperative pain, opioid consumption, and nausea following primary total knee arthroplasty (TKA).
Conditions Studied
Interventions
- DRUG Methylprednisolone
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2025-06-20 |
| Est. Completion | 2027-06-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07070882
The ClinicalTrials.gov registry entry for NCT07070882 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (78% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Methylprednisolone is the first listed.
NCT07070882 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07070882 about?
NCT07070882 is a clinical study titled "Oral Steroid Taper After Total Knee Arthroplasty". This study aims to evaluate the effectiveness of an oral methylprednisolone taper in reducing postoperative pain, opioid consumption, and nausea following primary total knee arthroplasty (TKA).
What is the current status of trial NCT07070882?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 130 participants. The study started on 2025-06-20. Estimated completion is 2027-06-20.
What conditions does trial NCT07070882 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT07070882?
The interventions under investigation include: Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT07070882?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07070882 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
CBD for Knee Osteoarthritis
RECRUITING · Phase 1
-
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction
ACTIVE NOT RECRUITING · Phase 1
-
Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.